Clinical Trial Update: An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers [Phase 4]

View source ↗

Summary

Phase 4 trial investigating safety of nivolumab in combination with ipilimumab for advanced cancers; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer | Phase 4 | Status: COMPLETED | Results posted: 2023-06-15